Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
China-based biopharma. Mazdutide (dual GCG/GLP-1) approved by China NMPA June 2025 for chronic weight management; first dual GCG/GLP-1 agonist globally. Partnership with Eli Lilly.
H1 2016-H2 2025
H2 2016-H2 2025(All available data)
H1 2016-H2 2025